Thep resence and likelihood of an alternatived iagnosis to pulmonaryembolism is an importantvariable of theWells'prediction rule fore stablishing clinicalp robability. We assessed whethere voking specific alternatived iagnoses would reduce the probability of pulmonarye mbolism enough to forego further testing.Weretrospectivelystudiedacohortof965 consecutivepatientsadmitted forsuspicionofpulmonary embolism at threemedical centers in Europe in whom the presence of an alternatived iagnosis at leasta sl ikelya sp ulmonary embolism was recordedbeforediagnostic testing.We divided the patients into 15 categoriesofalternativediagnoses evoked.Wethenassessedthe prevalenceofpulmonary embolismineach diagnostic category and compared it to the prevalenceofpulmonary embolisminareference group (patients with no alternativediagnosiso rad iagnosis less likelyt han pulmonary embolism).The Keywords Pulmonarye mbolism, alternative diagnosis,probabilitya ssessment prevalenceofpulmonary embolisminthe reference group was 48%.The presence of an alternativediagnosis as or more likely stronglyr educed the probabilityo fp ulmonary embolism( OR 0.15,95% CI: 0.1-0.2, p<0.01). In almost everyd iagnostic category, the prevalenceofpulmonary embolismwas much lower than in the reference group whithanoddsratio belowornear 0.2. Bronchopneumonia (OR0.4, 95% CI 0.2 to 0.7) and cancer (OR 0.6,95%CI0.3 to 1.5) reducedthe likelihood of pulmonary embolismtoalower extent. Evoking an alternativediagnosis at leastaslikelyaspulmonary embolismreduces the probabilityof the disease,but this effect is neverlarge enough to allow ruling it out without further testing,e speciallyw henb ronchopneumonia or cancerare the alternativediagnoses considered. 
Introduction
Several studieshavedemonstrated the importance of pre-testor clinical probability assessmentinsuspected pulmonaryembolism (1) (2) (3) , and it is nowincorporated in recent diagnostic algorithms (4) (5) (6) .Implicit assessmenthas been well validated (2, 7, 8) butm ight be less accuratew hen applied by physicians of lesser experience (9, 10) . Therefore, clinicalprediction rulesor scores have beendeveloped to provide amore standardized pretest probability assessment. The Wells' score (11) and the Geneva score (12) arethe most extensively validated (13) (14) (15) .
While the Geneva scoreusesobjective clinical variables (12) , the Wells' score(11) is composedofsix objectiveclinical variablesand one subjective variable,the presenceofanalternative diagnosis less likelythan pulmonaryembolism. Althoughconsideredb ys ome authorsa saweaknesso ft he Wells' scoreb ecauseo fi ts subjectivity (3, 12) a nd inter-raterv ariability (10, 16) , that item has aconsiderableweight: its presence is enoughto put the patient into the intermediate probability group of pulmonaryembolism. Conversely, evoking an alternative diagnosis at least as likelyaspulmonaryembolismshould lowerthe probability of the disease. However, to our knowledge,this effect and its impact on the probability of pulmonarye mbolismh aven ot beenreported.
In apreviousprospectiveoutcome study (15) on adiagnostic algorithm for pulmonary embolism, we recorded the likelihood and natureofalternativediagnosesfor each patient prior to diagnostict esting. We herein present ar etrospectivea nalysis of that cohorttodetermine:i)the influenceofspecific alternative diagnoseso nt he probability of pulmonarye mbolism; ii) whether evoking specific alternative diagnoseswould reduce the probability of pulmonarye mbolisme nough to foregof urther testing.
Methods

Patients
We analyzed adatabaseof965 consecutive patients admitted for suspected pulmonarye mbolisma tt hreeu niversity hospital emergency departments (Geneva,Switzerland;Lausanne, Switzerland;and Angers, France) fromOctober 1, 2000 to June30, 2002 (15) .T his wasaprospective outcome study designedt o evaluate adiagnostic strategyfor pulmonaryembolismcombining clinicalp robability assessment, plasma D-Dimerm easurement, lowerlimb venous ultrasonography(US)and helicalcomputed tomography( hCT), pulmonarya ngiographyb eing performedonlyincaseofanon conclusive diagnostic work-up. All patients above 18 years presenting to the emergency department with suspicion of pulmonary embolism, defined as acute onset of newo rw orsening shortness of breath or chest pain without anyo thero bvious etiology,w ere eligible.E xclusion criteria were: ongoing anticoagulant treatment for reasons other than thromboembolism, contraindication to CT scan [allergyt oi odine contrast agents or creatinine clearancebelow 30 ml/min calculated by the Cockroftformula (17)], informed consent impossible or patient refusal, suspected massive pulmonaryembolism withshock, pregnancy, survivalestimatedbelow three months, and follow-up impossible.
Clinical assessment
Physicians filledout astandardized datacollection formfor each patient recording demographic characteristics, risk factorsf or pulmonaryembolism, co-morbidities, clinical signs and symptoms of venous thromboembolism,results of the arterial blood gasa nalysis, and description of electrocardiogram and chest X-ray. We also askedi fa na lternatived iagnosis to pulmonary embolism wasevoked, and if so, its natureand likelihood compared with pulmonarye mbolism. Thea lternatived iagnosis could eitherbechosen from alist or writtendowninfree text on the data form(Table1). We requested thatonlythe most likely should be mentioned. The clinical probability of pulmonary embolismwas thenassessedbythe Geneva score (12) , whichcould be overridden by the physicians' clinical judgment in caseofdisagreement (13, 15) .
Diagnosticcriteria
Forp atients with alow or intermediate probability,p ulmonary embolism wasruled out if the D-dimer levelwas below 500 ng/ ml (highlys ensitive ELISA assay, Vidas DD; BioMérieux, Marcy l'Etoile,France), or if both US and hCTwere negative.In patients with ahigh clinical probability and anegativeUSand hCT,av entilation-perfusion pulmonary scintigraphyo rapulmonaryangiographywas performed. Pulmonary embolism was consideredestablished in patients with aproximaldeep venous thrombosis shown by US,apositivehelical CT or pulmonary angiogram, or ah igh-probability ventilation-perfusion scan ( 2) . Each patient had afollow-up of threemonths. 
Measurements
First,w er egrouped the alternatived iagnosese vokedb yt he emergencyp hysicians into 15 categoriesb yc onsensus among threeexperts blindedtothe prevalenceofpulmonaryembolism in anycategory. Care wastaken to obtain nosological groups that might be helpful and clinicallymeaningfulfor the physician in the emergencyd epartment (Table 1) .F or each diagnostic category, we determinedthe number of patients for whom the alternative diagnosis wasjudged at least as likelyaspulmonaryembolism. We calculated the prevalenceo fp ulmonarye mbolism, whichw ecompared to the prevalenceofpulmonaryembolism amongpatients for whom no diagnosis or adiagnosis less likely thanpulmonaryembolismwas evoked.
Statistics
Odds ratios for pulmonaryembolismand determination of 95% confidenceintervals were calculatedbystandard methods.
Results
Study sample
We excluded 51 (5%) of the 965 patients of the initialcohort, because the clinician in chargee vokedm ore than one alternative diagnosis, and one patient because of ac oding discordance. Hence, 913 patients (94%) were includedi nt his analysis. The patients were predominantlyw omen [534/913 (59%)],w ere around60years old(60 ±20), and the overallprevalenceofpulmonaryembolismwas 24%(218/913). The main clinicalpresentations were chestpain(70%) and/or dyspnea (66%). The characteristics of the cohortare listedinTable 2. Sixty-one patients (7%) had no alternativediagnosis to pulmonary embolism and 238( 26%) had an alternative diagnosis judged less likelyt han pulmonarye mbolism. Thea lternatived iagnosis wasj udged at least as likelyaspulmonaryembolismin614 of the 913 patients (67%). Overall, among patients for whom anydiagnosis wasevoked and judged at leastaslikelyaspulmonaryembolism, the prevalenceo fthe disease was1 2% (75/614). On the other hand,t he prevalenceofpulmonaryembolismamong patients with no alternatived iagnosis or ad iagnosis judged less likelyt han pulmonaryembolismwas 48%(143/299). These patients constitute the reference group with whichthe prevalenceofpulmonaryembolismi ne ach diagnostic categoryi sc ompared for the calculation of the odds ratios.
The odds ratiof or pulmonarye mbolismo fa ny alternative diagnosis at least as likelya sp ulmonarye mbolism, was0 .15 (95% CI: 0.1-0.2, p<0.01).
Diagnosticcategories
Table1shows the number of patients for whom the alternative diagnosis wasatleastaslikelyaspulmonaryembolismfor each of the 15 final diagnostic categories. The prevalenceofpulmonaryembolisminthe reference group (patients with no alternative diagnosis or alternative diagnosis less likelythan pulmonaryembolism) was48%. We determinedthe prevalenceofpulmonary embolism within each categoryand the corresponding odds ratios for pulmonary embolism (Table 3) .I nn earlye very diagnosticc ategoryt he prevalenceo fp ulmonarye mbolismw as muchl ower thani nt he reference group: psychiatric affection (2%), chest wall pain (7%), pericarditis (4%), acuteexacerbation of COPD( 7%),l eft ventricularf ailure( 14%),c oronary heart disease (14%), or acute bronchitis( 14%).All thosed iagnostic categoriesh ad odds ratios for pulmonary embolism belowo r near0 .2 (Table 3) . Bronchopneumonia considereda tl easta s likelyaspulmonaryembolismreduced the likelihoodofthe disease to alower extent (odds ratio0.4, 95% CI 0.2 to 0.7). In patients for whom cancerwas thought to be morelikelythan pulmonarye mbolism, however, there wasanon-significant trend towards alower likelihoodofpulmonaryembolism(odds ratio 0.6, 95% CI 0.3 to 1.5) ( Table 3 ).
Discussion
This analysis shows thatevoking an alternative diagnosis at least as likelyaspulmonaryembolismreduces the probability of pulmonary embolism approximately six-fold (odds ratio 0.15; 95% CI 0.1 to 0.2).A ctually,t he corresponding item in the Wells' scorew as whether an alternativediagnosis was less likelythan pulmonaryembolism, whichraisedthe probability of pulmonary embolism. Theodds ratio for pulmonaryembolismofanalternative diagnosis less likelythan pulmonaryembolismwas 6.2in the univariate and 4.6inthe multiple regression analysis in the originalderivation setofthe Wells' score (11) . As these odds ratios assess the same association and are each other's reciprocal, our resultsare very close(odds ratio for pulmonaryembolismof an alternativediagnosis less likelythan pulmonaryembolismin our cohort: 1/0.15 =6.7). Moreover,our data showthat the influenceofe voking specific alternative diagnosesonthe probability of pulmonaryembolismisv ariable.Most alternative diagnostic categories(psychiatric affection, pericarditis, chest wall pain, acutee xacerbation of COPD, left ventricularfailure, coronaryheartdisease or acute bronchitis) significantly reduce the probability of pulmonary embolism. Thegrouplabeled psychiatric affection, consisting mainlyofanxiety disordersaccompaniedbyhyperventilation, is particularly striking. When suchah ypothesis is consideredthe most likelydiagnosis by the clinician, the prevalence of pulmonaryembolismfalls below2%and would theoretically allowruling out venous thromboembolism without performing further tests. In fact,the number of patients is too small to allow ap recisem easurement of the likelihoodr atio and the "black box" effect -wedonot knowwhat particularities of the clinical presentation prompted the physician to evokethat hypothesiswould not justify that attitude.
Surprisingly, bronchopneumonia, the second largest category(n=67), does not lowerthe prevalenceofpulmonaryembolismt ot he same extent as the otherd iagnosesm entioned above,and the prevalenceofthe disease wasstill 27% in patients in whom this diagnosis wascontemplated. Although this is still significantly less thanthe prevalenceofpulmonaryembolismin patients without an alternative diagnosis, it suggests that thereis considerablemimicry betweenthe clinicalpresentation of pneumonia and pulmonary embolism. Noteworthy,plain chestX-ray findings were includedinthe clinicalassessmentand helpedthe physicians in the determination of an alternativediagnosis. On the otherhand,clear cases of bronchopneumonia presenting with high fever, purulent sputum and radiologicali nfiltrate were probably not included in our study.Indeed, our inclusion criterion wasasuspicion of pulmonary embolism defined as acute onset or newworsening shortness of breath or chest pain without anyotherobvious etiology.Although thatlastcriterion is necessarily subjective, it merelyreflectssensible clinical practice, since investigating allp atients admittedw ith dyspneaa nd/or chest pain for pulmonaryembolismwould hugelyincrease the number of patients submitted to unnecessary and costlytests. Therefore, patients includedinthis study whohad afinaldiagnosis of bronchopneumonia hadalessclear-cutclinical presentation thatexplains whyp ulmonarye mbolismw as evoked as ad iagnostic possibility.Furthermore,italso explains whyevoking bronchopneumonia in apatient suspected of pulmonary embolism did not reduce the likelihood of venous thromboembolism.
Finally, in patients with cancer presenting with suspected pulmonary embolism in whom clinicians estimated that cancer itself rather thanpulmonaryembolismwas the explanation of a patient'ssymptoms, the likelihood of pulmonaryembolismwas lowerthan in the comparison group, butthe difference wasnonsignificant.Therefore,although activecancer maycertainlyproduce respiratorys ymptomsd ue to locale xtension in case of bronchogenic carcinoma, or metastases, therebydecreasing the probability of pulmonary embolism, our results suggest that clinical judgment doesnot allowdistinguishing between thatexplanation and pulmonaryembolism. This maybedue to the fact thatcancer itself is an important risk factor forpulmonaryembolism. Hence, allpatients with cancer suspected of pulmonary embolism should have acomplete diagnostic workup.
What is the clinical significanceofour data?Evoking anyalternativediagnosis at leastaslikelyaspulmonaryembolismreduces the likelihoodofpulmonaryembolism, whichisconsistent with the Wells' score. This effect varies according to which alternatived iagnosis is evoked,b ut it is neverl arge enought o allowr uling out pulmonarye mbolismw ithoutf urther testing, particularly when bronchopneumonia and cancer are the alternative diagnosesunder consideration.
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